CFTR参与肺动脉高压发病机制的研究
该研究通过观察性和干预性实验,在人类组织和动物模型中探讨CFTR在肺动脉高压(PAH)发病中的作用。结果显示,特发性PAH患者及 monocrotaline 诱导的肺动脉高压大鼠肺動脈中CFTR表达降低,CFTR激活可诱导肺动脉舒张,而该舒张作用在PAH中减弱。长期抑制CFTR可增加右心室收缩压,与肺血管细胞增殖和血管新肌化相关。
要点
- 特发性PAH患者及PH大鼠肺動脈CFTR表达降低。
- CFTR激活诱导肺动脉舒张,该作用在PAH中减弱。
- 长期抑制CFTR增加右心室收缩压并促进肺血管重塑。
核心结论
- CFTR在人及动物PH模型的肺动脉平滑肌和内皮细胞中表达显著降低。
- CFTR抑制增加血管细胞增殖并显著减弱肺动脉舒张。
研究设计与样本
- 观察性与干预性实验,使用人类组织及动物模型(大鼠)。
- 方法包括逆转录定量PCR、共聚焦成像、电子显微镜及肌张力测定。
主要发现
- CFTR表达在特发性PAH患者及monocrotaline诱导PH大鼠的肺動脈中降低。
- CFTR激活诱导人、猪和大鼠肺动脉舒张,该作用在iPAH患者及monocrotaline或慢性缺氧诱导PH大鼠中减弱。
- 大鼠长期体内抑制CFTR显著增加右心室收缩压,与肺血管细胞增殖和血管新肌化相关。
- 严重囊性纤维化(F508del-CFTR)患者肺病理显示严重肺动脉重塑伴内膜纤维化和中膜肥厚。
- 纯合F508delCftr大鼠肺显示肺血管新肌化;monocrotaline暴露大鼠慢性抑制CFTR后右心室收缩压和舒张末压升高更明显。
临床怎么用
- CFTR通路可能成为肺动脉高压治疗的潜在靶点。
- 需进一步研究CFTR调节剂在PAH患者中的疗效和安全性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: A reduction in pulmonary artery relaxation is a key event in the pathogenesis of pulmonary arterial hypertension (PAH). Cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction in airway epithelial cells plays a central role in cystic fibrosis; CFTR is also expressed in pulmonary arteries and has been shown to control endothelium-independent relaxation. AIM AND OBJECTIVES: We aimed to delineate the role of CFTR in PAH pathogenesis through observational and interventional experiments in human tissues and animal models. METHODS AND RESULTS: Reverse-transcriptase quantitative PCR, confocal imaging and electron microscopy showed that CFTR expression was reduced in pulmonary arteries from patients with idiopathic PAH (iPAH) and in rats with monocrotaline-induced pulmonary hypertension (PH). Moreover, using myography on human, pig and rat pulmonary arteries, we demonstrated that CFTR activation induces pulmonary artery relaxation. CFTR-mediated pulmonary artery relaxation was reduced in pulmonary arteries from iPAH patients and rats with monocrotaline- or chronic hypoxia-induced PH. Long-term in vivo CFTR inhibition in rats significantly increased right ventricular systolic pressure, which was related to exaggerated pulmonary vascular cell proliferation in situ and vessel neomuscularisation. Pathologic assessment of lungs from patients with severe cystic fibrosis (F508del-CFTR) revealed severe pulmonary artery remodelling with intimal fibrosis and medial hypertrophy. Lungs from homozygous F508delCftr rats exhibited pulmonary vessel neomuscularisation. The elevations in right ventricular systolic pressure and end diastolic pressure in monocrotaline-exposed rats with chronic CFTR inhibition were more prominent than those in vehicle-exposed rats. CONCLUSIONS: CFTR expression is strongly decreased in pulmonary artery smooth muscle and endothelial cells in human and animal models of PH. CFTR inhibition increases vascular cell proliferation and strongly reduces pulmonary artery relaxation.
引用
- Le Ribeuz H, To L, Ghigna MR, et al. Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension. Eur Respir J. 2021. PMID: 33926975. doi:10.1183/13993003.00653-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。